In lamina V neurons of adult rat spinal cord slices, Metanicotine significantly increased sIPSC frequency relative to the pre-application control. In the presence of tetrodotoxin, Metanicotine treatment yielded an mIPSC frequency of 95 ± 3% of the pre-application control. [1]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Spontaneous inhibitory postsynaptic current frequency in rat spinal slices
Cell-based study · lamina V neurons of spinal cord slices prepared from adult rats [1]
In lamina V neurons of adult rat spinal cord slices, Metanicotine perfusion at 100 μM for 1 min significantly increased sIPSC frequency to 573 ± 189% of the pre-application control.
Literature-Reported Treatment Conditions
- Treatment concentration
- 100 μM
- Exposure duration
- for 1 min
- Method
- perfusion via a three-way stopcock
- Vehicle
- Krebs solution
- Co-treatment
- Other interventions in this design: CNQX 20 μM; APV 50 μM. Compound effect isolated by the comparison: sIPSC frequency before the applications of testing drugs is used as control.
Methods and source locations
Compound reported in the paper: Metanicotine; Compound label in the paper: RJR 2403
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > Effects of nicotine and nAChR agonists on spontaneous IPSCs in the lamina V neurons (S1, S11, S13, S14); Methods > Patch-clamp recordings from lamina V neurons (S52); Methods > Drug Applications (S53); Figure 2 legend (S75)
sIPSC frequency: sIPSC frequency; comparator: sIPSC frequency before the applications of testing drugs — Results > Effects of nicotine and nAChR agonists on spontaneous IPSCs in the lamina V neurons (S11, S13, S14)
Miniature inhibitory postsynaptic current frequency in rat spinal slices
Cell-based study · lamina V neurons of spinal cord slices prepared from adult rats [1]
In lamina V neurons of adult rat spinal cord slices, Metanicotine was perfused at 100 μM in the presence of tetrodotoxin at 0.5 μM. Under these conditions, mIPSC frequency was 95 ± 3% of the pre-application control.
Literature-Reported Treatment Conditions
- Treatment concentration
- 100 μM
- Method
- perfusion
- Vehicle
- Krebs solution
- Co-treatment
- Other interventions in this design: tetrodotoxin 0.5 μM; CNQX 20 μM; APV 50 μM. Compound effect isolated by the comparison: mIPSC frequency before the applications of testing drugs is used as control.
- Reported limits
- Not stated in the sentences used: schedule.
Methods and source locations
Compound reported in the paper: Metanicotine; Compound label in the paper: RJR 2403
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > Effects of nicotine and nAChR agonists on spontaneous IPSCs in the lamina V neurons (S1); Results > Effects of nicotine and nAChR agonists on mIPSCs in lamina V neurons (S19, S24, S25); Methods > Patch-clamp recordings from lamina V neurons (S52); Methods > Drug Applications (S53); Figure 3 legend (S81)
mIPSC frequency: mIPSC frequency; comparator: mIPSC frequency before the applications of testing drugs — Results > Effects of nicotine and nAChR agonists on mIPSCs in lamina V neurons (S19, S24, S25)